NTRK2 and Alzheimer disease: Chronic treatment with AD fluoxetine has been shown to reopen developmental-like plasticity in the adult rodent cortex [26], but also this treatment failed to facilitate the responsiveness of TrkB to ex vivo BDNF in the adult mouse brain.